• Like
Ireland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Ireland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

  • 108 views
Published

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
108
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Ireland Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018Report Details:Published:September 2012No. of Pages: 69Price: Single User License – US$2500Ireland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018SummaryGlobal Markets Direct’s new report, “Ireland Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018” provides key market data on the Ireland Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by Global Markets Direct’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Ireland Diabetes CareDevices market.- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Sanofi, Novo NordiskA/S , Eli Lilly and Company , Bayer HealthCare AG and others.
  • 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Ireland Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/195372-ireland-diabetes-care-devices-investment-opportunities-analysis-and-forecasts-to-2018.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 41.2 List of Figures 52 Introduction 72.1 What is This Report About? 73 Diabetes Care Devices In Ireland 83.1 Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, 2004-2018 83.2 Diabetes Care Devices, Ireland, Company Share (2010-2011) 134 Glucose Monitoring In Ireland 154.1 Glucose Monitoring Overall Revenue, (2004-2018) 154.1.1 Blood Glucose Meters, Revenue (2004-2018) 194.2 Glucose Monitoring Overall Volume (2004-2018) 234.2.1 Blood Glucose Meters, Volume (2004-2018) 274.3 Glucose Monitoring Average Price (2004-2018) 294.4 Glucose Monitoring Distribution Share (2010-2011) 304.5 Glucose Monitoring, Ireland, Company Share (2010-2011) 315 Insulin Delivery In Ireland 335.1 Insulin Delivery Overall Revenue, (2004-2018) 335.1.1 Insulin Pens, Revenue (2004-2018) 375.1.2 Insulin Pumps, Revenue (2004-2018) 415.2 Insulin Delivery Overall Volume (2004-2018) 435.2.1 Insulin Pens, Volume (2004-2018) 475.2.2 Insulin Pumps, Volume (2004-2018) 515.3 Insulin Delivery Average Price (2004-2018) 535.4 Insulin Delivery Distribution Share (2010-2011) 54
  • 3. 5.5 Insulin Delivery, Ireland, Company Share (2010-2011) 556 Overview of Key Companies in Ireland Diabetes Care Devices Market 576.1 F. Hoffmann-La Roche Ltd. 576.1.1 Company Overview 576.2 LifeScan, Inc. 576.2.1 Company Overview 576.3 Sanofi 586.3.1 Company Overview 586.4 Novo Nordisk A/S 586.4.1 Company Overview 586.5 Eli Lilly and Company 596.5.1 Company Overview 596.6 Bayer HealthCare AG 596.6.1 Company Overview 596.7 Abbott Laboratories 606.7.1 Company Overview 606.8 Becton, Dickinson and Company 606.8.1 Company Overview 606.9 Medtronic, Inc. 616.9.1 Company Overview 616.10 Terumo Corporation 616.10.1 Company Overview 616.11 Animas Corporation 616.11.1 Company Overview 616.12 Nipro Corporation 626.12.1 Company Overview 627 Appendix 637.1 Global Markets Direct Research Methodology 637.2 Definitions of Markets Covered in the Report 647.2.1 Diabetes Care Devices 647.3 Secondary Research 677.4 Primary Research 677.5 Models 687.6 Forecasts 687.7 Expert Panel Validation 687.8 Currency Conversion 697.9 Contact Us 697.10 Disclaimer 691.1 List of TablesTable 1: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, 2004-2018 8Table 2: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, Historic, 2004-
  • 4. 2011 10Table 3: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 12Table 4: Diabetes Care Devices, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 14Table 5: Glucose Monitoring, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 16Table 6: Glucose Monitoring, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 18Table 7: Blood Glucose Meters, Ireland, Revenue ($m*) USD Constant, by Sub-Segment, Historic,2004-2011 20Table 8: Blood Glucose Meters, Ireland, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 22Table 9: Glucose Monitoring, Ireland, Volume (Units) by Segment, Historic, 2004-2011 24Table 10: Glucose Monitoring, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 26Table 11: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 27Table 12: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-201828Table 13: Glucose Monitoring, Ireland, Average Price ($), Historic, 2004-2011 29Table 14: Glucose Monitoring, Ireland, Average Price ($), Forecast, 2011-2018 29Table 15: Glucose Monitoring, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 30Table 16: Glucose Monitoring, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 32Table 17: Insulin Delivery, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-201134Table 18: Insulin Delivery, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 36Table 19: Insulin Pens, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 38Table 20: Insulin Pens, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 40Table 21: Insulin Pumps, (Traditional Insulin Pumps), Ireland, Revenue ($m) USD Constant,Historic, 2004-2011 41Table 22: Insulin Pumps, (Traditional Insulin Pumps), Ireland, Revenue ($m) USD Constant,Forecast, 2011-2018 42Table 23: Insulin Delivery, Ireland, Volume (Units) by Segment, Historic, 2004-2011 44Table 24: Insulin Delivery, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 46Table 25: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 48Table 26: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 50Table 27: Insulin Pumps, (Traditional Insulin Pumps), Ireland, Volume (Units), Historic, 2004-201151
  • 5. Table 28: Insulin Pumps, (Traditional Insulin Pumps), Ireland, Volume (Units), Forecast, 2011-2018 52Table 29: Insulin Delivery, Ireland, Average Price ($), Historic, 2004-2011 53Table 30: Insulin Delivery, Ireland, Average Price ($), Forecast, 2011-2018 53Table 31: Insulin Delivery, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-201154Table 32: Insulin Delivery, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011561.2 List of FiguresFigure 1: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, 2004-2018 8Figure 2: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, Historic, 2004-2011 9Figure 3: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 11Figure 4: Diabetes Care Devices, Ireland, Company Share (%), 2011 13Figure 5: Glucose Monitoring, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 15Figure 6: Glucose Monitoring, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 17Figure 7: Blood Glucose Meters, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 19Figure 8: Blood Glucose Meters, Ireland, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 21Figure 9: Glucose Monitoring, Ireland, Volume (Units) by Segment, Historic, 2004-2011 23Figure 10: Glucose Monitoring, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 25Figure 11: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-201127Figure 12: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-201828Figure 13: Glucose Monitoring, Ireland, Company Share (%), 2011 31Figure 14: Insulin Delivery, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 33Figure 15: Insulin Delivery, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 35Figure 16: Insulin Pens, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 37Figure 17: Insulin Pens, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 39Figure 18: Insulin Pumps, (Traditional Insulin Pumps), Ireland, Revenue ($m) USD Constant,Historic, 2004-2011 41Figure 19: Insulin Pumps, (Traditional Insulin Pumps), Ireland, Revenue ($m) USD Constant,
  • 6. Forecast, 2011-2018 42Figure 20: Insulin Delivery, Ireland, Volume (Units) by Segment, Historic, 2004-2011 43Figure 21: Insulin Delivery, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 45Figure 22: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 47Figure 23: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 49Figure 24: Insulin Pumps, (Traditional Insulin Pumps), Ireland, Volume (Units), Historic, 2004-201151Figure 25: Insulin Pumps, (Traditional Insulin Pumps), Ireland, Volume (Units), Forecast, 2011-2018 52Figure 26: Insulin Delivery, Ireland, Company Share (%), 2011 55Figure 27: Global Markets Direct Methodology 63Contact: sales@reportsandreports.com for more information.